Metagenomi, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
MGX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
5959 Horton Street, 7 Th Floor, Emeryville, CA

Insiders trading volume in the past year

Metagenomi, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bayer Healthcare Llc 10%+ Owner $11.7M Feb 13, 2024
Sebastian Bernales Director $6.62M Apr 1, 2024
Novo Holdings A/S 10%+ Owner $5.01M Feb 9, 2024
Brian C. Thomas Director $4.55M -$23.8K -0.52% Sep 5, 2025
Jian Irish Chief Executive Officer, Director $905K -$14.1K -1.53% Sep 5, 2025
Simon Harnest Title: Chief Investment Officer and Senior Vice President of Strategy $353K Apr 1, 2024
Pamela Wapnick Chief Financial Officer $305K -$9K -2.87% Sep 5, 2025
Simren Delaney Title: Vice President of Intellectual Property and Legal Operations $270K Apr 1, 2024
Luis Borges Chief Scientific Officer $200K Apr 1, 2024
Sarah B. Noonberg Chief Medical Officer $191K -$9.17K -4.58% Jun 6, 2025
Matthew Wein Title: General Counsel, Compliance Officer and Corporate Secretary $184K -$2.45K -1.31% Sep 5, 2025
Juergen Eckhardt Director Jun 10, 2025
Willard H. Dere Director Jun 10, 2025
Eric Bjerkholt Director Jun 10, 2025
Laurence Reid Director Sep 2, 2025

Recent Insider Transactions by Companies or Individuals for Metagenomi, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.